Abstract:Beyond mesoporous silica nanoparticles (MSNs), mesoporous organosilica nanoparticles (MONs) have been becoming an even more attractive alternative to the traditional organic or inorganic nanomaterials in biomedical applications, especially for drug delivery, due to its high surface area, stable physicochemical properties, low toxicity, high biocompatibility, and particularly the devisable features decided by the incorporated organic fragments. However, it is still challenging to fabricate uniform ultrasmall MONs with tunable composition, morphology and fine biodegradability. Herein, we report, on the large-scale fabrication of monodispersed and molecularly organic-inorganic hybrid MONs with framework-incorporated physiologically active thioether bonds, controllable nanostructure, composition and morphology, which provides the material foundation for exploring the versatile biomedical applications of organosilica nanosystems. The hybrid MONs of less than 50 nm in particle size exhibit the unique reduction-responsive biodegradation behavior, and the biodegradation rate is significantly higher than that of traditional mesoporous silica nanoparticles with pure inorganic SiOSi framework. The reductive microenvironment-triggered biodegradation of MONs induces the concurrent reduction-responsive anticancer drug releasing from MONs, enabling tumor-specific drug delivery. Importantly, these biocompatible and biodegradable MONs exhibit significantly improved drug-delivery efficiency and enhanced tumor-suppressing effect for combating cancer. Based on the facile and large-scale fabrication of MONs with controllable key structure/composition/morphology parameters, unique tumor microenvironment-responsive biodegradation behavior and high performance for drug delivery, the MONs therefore show more promising potentials for clinical translation as compared to traditional MSNs.

Organic Chemistry Tool for Nanoparticles Monofunctionalization and Their Biomedical Applications

Detoxification and Functionalization of Gold Nanorods with Organic Polymers and Their Applications in Cancer Photothermal Therapy

Elaboration of Hybrid Organic-inorganic Nanoparticles

Monodisperse nanoparticles for catalysis and nanomedicine

Surface tailoring of nanoparticles via mixed-charge monolayers and their biomedical applications.

Chemical Control over Cellular Uptake of Organic Nanoparticles by Fine Tuning Surface Functional Groups.

Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles

Biofunctionalization of Nanomaterials

Synthesis and Applications of Nanoparticles in Biology

Surface Functionalisation of Upconversion Nanoparticles with Different Moieties for Biomedical Applications

Metal-organic Framework-Based Nanomaterials for Biomedical Applications

Core–shell Structural Iron Oxide Hybrid Nanoparticles: from Controlled Synthesis to Biomedical Applications

Synthesis of Different Nanoparticles for Biological Application

Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery

Surface Modification: How Nanoparticles Assemble to Molecular Imaging Probes

Engineering Organic/Inorganic Nanohybrids Through RAFT Polymerization for Biomedical Applications.

Nanoscale Metal−Organic Frameworks and Their Nanomedicine Applications

Surface Modification of Magnetic Iron Oxide Nanoparticles

Progress in ligand design for monolayer-protected nanoparticles for nanobio interfaces

Synthesis and biomedical application of nanocomposites integrating metal-organic frameworks with upconversion nanoparticles

Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization Strategies